← FDA Drug Approvals (Drugs@FDA)
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2021-12-13
Drug application
- FDA Application #
ANDA213948- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE
- Generic name
- FLUTICASONE PROPIONATE AND SALMETEROL
- Active ingredients
- FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
- Dosage form
- POWDER
- Route
- INHALATION
- Marketing status
- Prescription
- Sponsor
- TEVA PHARMS USA
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- First approval
- 2021-12-13
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown